Osemitamab
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Osemitamab, covering 2025-12-17 to 2025-12-17. Get the full timeline:
Most recent: Clinical Trial Update: Combination of Osemitamab (TST001), Pembrolizumab and Chemotherapy as First-line Therapy in Advanced or Metastatic GC/GEJ Adenocarcinoma [Phase 3]